 The gut microbiome is a promising target for the development of GI tract therapies yet it has been under exploited due in part to a lack of tools to control and manipulate complex microbial communities . To date the most common approach in harnessing bacteria for therapeutic purposes has been to deliver

@highlight The gut microbiome is becoming an increasingly important druggable target
@highlight Phages as gut microbiome gene delivery vectors allow for
@highlight engineering
@highlight There are numerous challenges in designing microbiome targeted phage vectors
